The McEwen Investment Report
David McEwen
Head Researcher
Professional Journalist Turned Investment Analyst
After writing for The Financial Times, Reuters News Service, National Business Review David turned his talents towards investment analysing. Over 30 years of watching the markets David offers timely and easy-to-understand commentary on shares that he classifies through the use of 9 unique key criteria.
The McEwen Investment Report
Decades of success
The McEwen Investment Report was established in New Zealand in 1998, and has since provided readers with accurate, timely and effective guidance to the share market. Growing to become a global title, offering fresh thinking and analysis of shares on the NZ, Australian, UK, and US stock markets. The newsletter offers easy-to-understand commentary on shares to buy, hold and sell. Using David McEwen's unique 9 Key Criteria we find financially sound businesses that are temporarily undervalued by other investors.
This has proven to be a low-risk strategy that to date has delivered returns that are substantially above the overall market.
The report is refreshingly free of jargon and complicated calculations, making it easy to read and understand, while every company profiled comes with a firm trading recommendation.
Information That Pays
16.49% In 3 Days!
Pro Medicus
Tip given in The McEwen Platinum Club.
David McEwen advised the members of the McEwen Platinum Club to purchase Pro Medicus stocks on Thursday, the 6th of August. Three days later, he advised them to sell for a handsome 16.49% profit!
25.40% In 5 Weeks!
Northern Star Resources
Tip given in The McEwen Investment Report.
On Thursday the 20th of June, David advised our members to invest in Northern Star Resources. Five weeks later, he advised they sell. Our readers made 25.40% in just 5 weeks!
Checkout some of Dave's latest updates!
#Investors are so enthusiastic about the NZ #stockmarket that it’s back to where it was in January. Then, the #NZX50 was hitting a record high amid a robust #economy, strong #tourism and low unemployment. Given where we are now, it makes no sense that we are back to such levels https://t.co/wyRP3xWpdb
Robinhood, a ‘free’ broking service is finding lots of appeal w/ the younger generation. The number of accounts has exploded (light blue line) but older investors are slower to return to the market & have liquidated billions of dollars in positions in recent months (dark line) https://t.co/4PlJ69BG9i
Fisher & Paykel Healthcare has turned in a strong #financial result and is looking good for a 20%+ growth in #earnings next year. But at 57 times forecast earnings it looks like the good news is priced into the shares and my gut feel is that #investors should proceed #carefully https://t.co/xqQEvrjp6R
3 dates to put in your calendar:They represent where & when Dow Jones Index in the USA could peak, if the market follows the trajectory of one of the 3 previous greatest bear market rallies. But all 3 recoveries were followed by declines so investors need to proceed with caution https://t.co/yMULttjzTk
Save up to 50% on a subscription to the McEwen Investment Report!
Receive a money back guarantee on any unsent issues.
Join The McEwen Team!
Get To Know Us!
$74.90$0.00McEwen Investment Report
$894.90McEwen Platinum Club
$4,450.50$2,249.90
Great Info & Fantastic Insights
5/5
My average buy price for A2 Milk, which you recommended, is 66c compared with the current price of over $12.00. I still have 5715 shares and current gains total $87,500.00. Over 46 yrs of fiddling about on the NZ market this is by far the best return.
- A McCullough, Christchurch
Good Picks
4.5/5
I made 30% in two months from your pick of Evraz. I don’t know how you find such shares that others have never even heard of, but I am very pleased that you do.
- L Jollands, Auckland
